
TSE:ZUH
This summary was created by AI, based on 1 opinions in the last 12 months.
The BMO EqWt US HthCare Hedged CAD, represented by the symbol ZUH-T, has garnered positive reviews for its equal-weight strategy that mitigates concentration risk often found in mega-pharmaceutical firms. Experts appreciate the focus on a variety of sectors within healthcare, such as pharmaceuticals, biotechnology, and healthcare services. This diversified approach contributes to lower volatility, making it an attractive option for investors looking for defensive growth amidst current market conditions. The sector benefits from steady demand and robust balance sheets, showcasing resilience against economic fluctuations. Moreover, experts highlight a promising future driven by healthcare innovations fueled by advancements in AI, which are anticipated to greatly enhance growth prospects for the sector.
This has more health care in it, rather than pharmaceuticals. FT AlphaDEX US Health Care (FHH-T) is a rule based ETF in the healthcare area, but they use the Russell 1000, drilling down a little bit more into some of the smaller and less recognizable companies. With this one he is not buying a US health care with an impoverished Cdn$.
US healthcare is one area that hasn’t been on people’s radar for quite a while but has been performing pretty well. Healthcare is typically one or 2 products that really drive the earnings of each company. This is an equal weighted ETF, so regardless of which company does well, as long as the overall sector does well it should do well.
He likes this because it is equal weighted and hedged against the decline in the US$. You can quite comfortably put this into your portfolio.